GlassScriptPhysician profile
Aruna Souri
NPI 1922685296
$796.81
in general payments reported to CMS, 2019-2025
10 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $67.05 · 2024: $450 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $205.20 | 2023-2024 | Fintepla, Zilbrysq, Nayzilam |
| Sk Life Science, INC. | $159.78 | 2025 | |
| Jazz Pharmaceuticals INC. | $125.99 | 2024 | |
| Alexion Pharmaceuticals, INC. | $122.44 | 2024 | |
| Abbvie INC. | $44.39 | 2025 | |
| Tanabe Pharma America, INC. | $42.32 | 2023-2024 | |
| Pfizer INC. | $29.93 | 2025 | |
| Lundbeck LLC | $24.75 | 2025 | Vyepti |
| Lilly USA, LLC | $21.09 | 2024 | Emgality, Reyvow |
| Ani Pharmaceuticals, INC. | $20.92 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aruna Souri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.